Lilly(LLY) - 2025 Q1 - Earnings Call Presentation

Dave Ricks, Chair and Chief Executive Officer Q1 2025 Financial Results Lucas Montarce, Chief Financial Officer R&D Update Dan Skovronsky, M.D., Ph.D., Chief Scientific Officer Q1 2025 EARNINGS CALL ELI LILLY AND COMPANY Agenda Introduction and Key Events Closing Remarks Dave Ricks, Chair and Chief Executive Officer Question & Answer Session 3 2025 Q1 EARNINGS Safe Harbor Provision and Other Information This presentation contains forward-looking statements that are based on management's current expectations ...